December 22, 2020: Dowd Scheffel filed an amicus brief in Glaxosmithkline, LLC v. Teva Pharmaceuticals USA, Inc before the Federal Circuit. The amicus brief was filed on behalf of fifty-seven law, economics, business, health and medicine professors. The brief outlines how the panel majority in the case did not follow its own precedent in holding that corporations engaging in skinny labeling could be held liable for inducing patent infringement. This reduction of generic compe

December 8, 2020: Matthew J. Dowd of Dowd Scheffel was honored to work with Chief Judge Michel (ret.) to assist with filing an amicus curiae brief at the Federal Circuit in Zaxcom, Inc. v. Lectrosonics, Inc., No. 20-1921 (Fed. Cir. 2022). Zaxcom addresses an important issue in patent law concerning obviousness challenges—namely the requisite standards for showing a nexus of secondary considerations that relate to the patented invention.The firm stepped in after the unfortunat